Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03091803 : QSM and Regional DCE MRI Permeability Using GOCART Technique
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patient with suspected intracranial neoplasm scheduled for routine MRI with GBCA
(gadolinium naive patients)

- Willingness to comply with the study protocol

Exclusion Criteria:

- Contraindications for MRI or GBCA (standard of care)

- Abnormal renal function with estimated glomerular filtration rate (eGFR) less than 30
mL/min/m^2 based on creatinine obtained within last 30 days

- History of previous administration of GBCA
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03091803      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740